Ligand validation:6XPO

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6XPO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6XPO_NAG_B_601	27%	76%	0.237	0.885	0.35	0.57	-	-	1	0	100%	0.9333
6XPO_NAG_A_601	23%	82%	0.243	0.867	0.4	0.39	-	-	0	0	100%	0.9333
6XPO_NAG_A_603	5%	91%	0.302	0.699	0.2	0.35	-	-	0	0	100%	0.9333
6XPO_NAG_C_602	3%	91%	0.408	0.746	0.25	0.32	-	-	0	0	100%	0.9333
6XPO_NAG_A_604	2%	65%	0.483	0.727	0.63	0.7	-	1	0	0	100%	0.9333
6XPO_NAG_A_602	0%	69%	0.792	0.547	0.47	0.7	-	-	1	0	100%	0.9333
6XPO_NAG_C_601	0%	68%	0.758	0.227	0.63	0.6	1	-	2	0	100%	0.9333
6P6P_NAG_F_701	34%	49%	0.176	0.858	0.76	1.21	1	1	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.